Phil Gutry

Insider Reports History

Location
Baltimore, MD
Signature
/s/ Zed Zduniak, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phil Gutry:

Company Role Class Num Shares Value Price $ Report Date Ownership
Graphite Bio, Inc. CHIEF BUSINESS OFFICER Common Stock 299,941 $1,223,759 $4.08 11 Apr 2022 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 4,718 30 Sep 2021 Direct

Insider Reports Filed by Phil Gutry

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LENZ Graphite Bio, Inc. 11 Apr 2022 1 +$20,050 4 CHIEF BUSINESS OFFICER 13 Apr 2022, 19:35
LENZ Graphite Bio, Inc. 16 Feb 2022 1 $0 4 CHIEF BUSINESS OFFICER 18 Feb 2022, 17:56
AVTX Avalo Therapeutics, Inc. 01 Dec 2021 0 $0 4 Director 03 Dec 2021, 19:36
AVTX Avalo Therapeutics, Inc. 30 Sep 2021 1 $0 4 Director 04 Oct 2021, 16:45
AVTX Cerecor Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 16:06
LENZ Graphite Bio, Inc. 24 Jun 2021 0 $0 3 CHIEF BUSINESS OFFICER 24 Jun 2021, 21:16
AVTX Cerecor Inc. 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:41
LENZ Graphite Bio, Inc. 13 Jan 2021 10 +$148,093 4 CHIEF BUSINESS OFFICER 01 Jul 2021, 19:00